OSLO, May 29 2026: The Annual General Meeting of EXACT Therapeutics AS
("EXACT-Tx", Euronext Growth: EXTX), will be held as a virtual meeting at 10:30
CEST on June 12, 2026.
The formal notice of the Annual General Meeting is attached and provides further
information on the proceedings.
The documents are also available at www.exact-tx.com.
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com
John M. Edminson, CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com
About EXACT Therapeutics:
EXACT Therapeutics is a clinical-stage precision medicine company utilizing the
power of ultrasound to activate the proprietary drug PS101 and enhance the
clinical benefit of oncology therapies. PS101 has a unique mode of action and
may be combined with a wide range of therapeutic agents within oncology and
across a multitude of other indications, including brain diseases. EXACT
Therapeutics' shares are traded on Euronext Growth Oslo (EXTX). Further
information may be found here: www.exact-tx.com
may be found here: www.exact-tx.com \